Edible mushrooms have been studied for their potential to reduce hyperglycemia by looking into their antioxidant defenses, carbohydrate metabolism pathways, α-glucosidase and aldose reductase inhibitory activities, β-cell enhancement, and insulin-releasing activity. This evidence concerns the gene AKR1B1 and Hyperglycemia.